CHKA and cancer: Chk-α downregulation also shifted cancer cells towards a more immunosuppressive profile through metabolic reprogramming, increasing the production of metabolites such as lactate [12], glutamate [14], MTA [60], or glutamine [61], which have been linked to increased immune resistance of cancer cells.